Health Monitor Liechtenstein: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Monitor Liechtenstein.

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Press releases published on January 14, 2026

January 14, 2026

Amid COVID-19 Vaccine Confusion, New Tool Helps Guide Decision-Making

GlobeNewswire

January 14, 2026

Ensora Health Becomes New Corporate Partner of ASHA

GlobeNewswire

January 14, 2026

Aviv Clinics Becomes First Undersea & Hyperbaric Medical Society Accredited Center Focused on Treating Emerging Indications in the U.S.

GlobeNewswire

January 14, 2026

Protex AI Celebrates Safety Achievement with Bendix Commercial Vehicle Systems After 84% Reduction in At‑Risk Behaviors

GlobeNewswire

January 14, 2026

SOL Mental Health Celebrates Growth and Local Impact in 2025

GlobeNewswire

January 14, 2026

Anresco NJ Labs Expands Nationwide Testing Network with New Bi-Coastal Laboratories for Amazon Readiness

GlobeNewswire

January 14, 2026

Ultrahuman and Click Therapeutics partner to launch the world’s first biomarker-driven migraine management tool based on FDA-authorized technology

GlobeNewswire

January 14, 2026

Omniscient Secures New CPT® Code for Connectomic Analysis, Validating the Clinical Utility of Brain Network Mapping

GlobeNewswire

January 14, 2026

Cosmos Health Announces Initiation of Analyst Coverage with $4.50 Valuation by Zacks Small-Cap Research

GlobeNewswire

January 14, 2026

AscellaHealth Launches Strategic Pharmacy Benefits Enablement Platform to Address 2026 Healthcare Cost and Access Challenges

GlobeNewswire

January 14, 2026

NJ Opioid Prescribers Learn About Safer Alternatives Through CME Impacting 1.5 Million Patients

GlobeNewswire

January 14, 2026

Affidea übernimmt eine Mehrheitsbeteiligung an LabPoint von der Lindenhofgruppe und stärkt damit seine Kompetenzen in Diagnostik und Labormedizin

GlobeNewswire

January 14, 2026

Affidea Svizzera acquisisce la partecipazione di maggioranza in LabPoint, dopo la cessione da parte del Gruppo Lindenhof, rafforzando così la propria offerta nel campo della diagnostica e della medicina di laboratorio

GlobeNewswire

January 14, 2026

Affidea Suisse acquiert la participation majoritaire dans LabPoint cédée par le groupe Lindenhof, et renforce son offre de diagnostic et de médecine de laboratoire

GlobeNewswire

January 14, 2026

Affidea acquires a majority stake in LabPoint from Lindenhofgruppe, strengthening its diagnostics and laboratory medicine capabilities

GlobeNewswire

January 14, 2026

TellDx-Enabled Circulating Tumor Cell Analysis Predicts Response to DLL3-Targeted Therapy in Small Cell Lung Cancer

GlobeNewswire

January 14, 2026

Eagle Pharmaceuticals Announces Divestiture of Barhemsys

GlobeNewswire

January 14, 2026

SoldierStrong Announces 2025 Recipients of Annual Individual Commitment to Service Award

GlobeNewswire

January 14, 2026

BPD Healthcare to lead The Agency Network within MJH Life Sciences, integrating pharmaceutical expertise with healthcare delivery insight

GlobeNewswire

January 14, 2026

HealthTab™ to Expand Across North East London

GlobeNewswire